Skip to content

Patient Perspective on Remote Monitoring of Cardiovascular Implantable Electronic Devices

Remote Monitoring of Heart Failure Patients With Cardiovascular Implantable Electronic Device: The Patient Perspective

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01691586
Acronym
REMOTE-CIED
Enrollment
600
Registered
2012-09-24
Start date
2013-04-13
Completion date
2018-01-15
Last updated
2018-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congestive Heart Failure

Keywords

implantable defibrillators, remote patient monitoring, patient-reported outcomes, cost-effectiveness

Brief summary

A relatively new and promising development in the area of cardiovascular implantable electronic device therapy is remote patient monitoring (RPM). RPM systems can interrogate the device automatically and send the data from the patients' home to the physician, thereby reducing in-clinic follow-ups. The purpose of this study is to evaluate the effect of RPM + in-clinic follow-up versus in-clinic follow-up only on patient-reported health status and device-acceptance after implantation with an implantable cardioverter defibrillator (ICD) or cardiac resynchronization defibrillator (CRT-D). Secondary objectives are (1) to identify subgroups of patients who prefer RPM over in-clinic visits or vice versa due to specific clinical and psychological factors and (2) To investigate the cost-effectiveness of RPM + in-clinic follow-up compared to in-clinic follow-up only.

Interventions

Remote monitoring of ICD and heart failure data

OTHERIn-Clinic check-ups

Calender-based In-Clinic ICD check-up

Sponsors

Boston Scientific Corporation
CollaboratorINDUSTRY
Tilburg University
CollaboratorOTHER
Erasmus Medical Center
CollaboratorOTHER
UMC Utrecht
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* first time ICD/CRT-D implanted at one of the participating centers * left ventricular ejection fraction \<35% * NYHA functional class II or III symptoms * ICD/CRT-D device compatible with the LATITUDE(r) RPM system from Boston Scientific

Exclusion criteria

* On the waiting list for heart transplantation * History of psychiatric illness others than affective/anxiety disorders * Cognitive impairments * Insufficient knowledge of the language to fill in the questionnaires

Design outcomes

Primary

MeasureTime frameDescription
Patient-reported health status24 months23-item Kansas City Cardiomyopathy Questionnaire (KCCQ)
Patient-reported device acceptance24 months12-item Florida Patient Acceptance Scale (FPAS)

Secondary

MeasureTime frameDescription
Patient-reported satisfaction with care24 months* Visual Analogue Scale ranging from 0-100 (with higher score representing more satisfaction with care) * 26-item self-made questionnaire to assess satisfaction with RPM
Cost-effectiveness24 monthsData regarding health care utilization is gathered from hospitals and patients.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026